Physician profile
Pratap Agusala
NPI 1215040779
$1,591.75
in general payments reported to CMS, 2019-2025
19 companies · $302 in 2025
The $302 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $158 · 2020: $62.68 · 2021: $193 · 2022: $443 · 2023: $99.34 · 2024: $334 · 2025: $302.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $735.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $735.16 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $257.75 | 2019-2022 | |
| Medtronic, INC. | $182.01 | 2022-2025 | Symplicity G3, Onyx Frontier |
| Amgen INC. | $178.20 | 2023-2025 | Repatha, Repatha |
| Boston Scientific Corporation | $147.65 | 2021-2025 | Bodyguardian, Watchman Access System |
| Novartis Pharmaceuticals Corporation | $137.23 | 2020-2024 | |
| Biotronik INC. | $136.66 | 2022 | |
| Abbott Laboratories | $116.05 | 2022-2025 | Thoratec Heartmate 3 Lvas Implant Kit, Cardiomems |
| Pfizer INC. | $100.40 | 2021-2025 | |
| Kestra Medical Technology Services, INC. | $64.77 | 2024 | Assure Wcd |
| Merck Sharp & Dohme LLC | $51.34 | 2022-2023 | Verquvo |
| Heartflow, INC. | $49.53 | 2024-2025 | |
| E.R. Squibb & Sons, L.L.C. | $35.84 | 2025 | Eliquis, Camzyos |
| Edwards Lifesciences Corporation | $27.65 | 2022 | |
| Alnylam Pharmaceuticals INC. | $25.93 | 2021 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $23.26 | 2019-2025 | Lifevest |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $17.91 | 2021 | |
| Avinger INC. | $15.47 | 2020 | |
| Novo Nordisk INC | $12.70 | 2020 | |
| Tactile Systems Technology INC | $11.40 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Pratap Agusala listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.